Prescribing information, brochures, and a Sagent representative when you need one.
PDFs open in a new tab.
Complete approved labeling, including indications, dosage and administration, contraindications, warnings and precautions, use in specific populations, adverse reactions and storage.
Download
Two-page printable reference with product details, NDC and wholesaler information.
DownloadThree ways to reach the Sagent team.
Speak with a local specialty rep about Zyogreen®, including samples, institutional evaluation, and ordering logistics.
Request a repSubmit a clinical or scientific question to Sagent. Responses include literature references where applicable.
Submit an inquirySafetyReport a suspected adverse reaction to Sagent Pharmaceuticals. Also report to FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Report an eventZyogreen is indicated for fluorescence imaging of vessels, blood flow, and tissue perfusion; fluorescence imaging of extrahepatic biliary ducts; lymphatic mapping in cervical and uterine cancer; and ophthalmic angiography, in the populations specified in the full Prescribing Information.
Zyogreen is contraindicated in patients with known hypersensitivity to indocyanine green.
Hypersensitivity reactions, including anaphylaxis, have been reported with indocyanine green. Monitor patients for hypersensitivity and have emergency equipment and trained personnel readily available.
The most common adverse reactions reported with indocyanine green products include hypersensitivity reactions. See full Prescribing Information for complete safety information.
To report SUSPECTED ADVERSE REACTIONS, contact Sagent Pharmaceuticals at 1-866-625-1618 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see the full Prescribing Information for additional Important Safety Information.
